NCT01331590View on ClinicalTrials.gov

Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2015

Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Interventions
DRUG

G-CSF

DRUG

Ifosfamide

DRUG

Etoposide

DRUG

Dexamethasone

DRUG

Mesna

Trial Locations (2)

60637

University of Chicago Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01331590 - Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter